Evidence map›Paper›PMID 42504587›Full record

ArticleJournal of cell science2026

Stress- and mitosis-dependent phosphorylation of NIFK on Ser247.

Sibylle Schleich, Aurelio A Teleman

Abstract read
In one paragraph

Article in Journal of cell science, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Sibylle SchleichGerman Cancer Research Center (DKFZ) Heidelberg, Division B140, 69120 Heidelberg, Germany.
Aurelio A TelemanGerman Cancer Research Center (DKFZ) Heidelberg, Division B140, 69120 Heidelberg, Germany.ORCID 0000-0002-4237-9368

Funding

Deutsches KrebsforschungszentrumDeutsches Krebsforschungszentrum n/a
6 · The paper itself

Abstract

NIFK is a nucleolar protein involved in ribosome biogenesis that interacts with Ki-67 (also known as MKI67) and is recruited to the perichromosomal layer during mitosis. NIFK expression is elevated in multiple cancers, and its expression correlates with poor prognosis. Although NIFK is highly phosphorylated, the regulation and functional significance of NIFK phosphorylation is not fully understood. Here, we identify Ser247 as a stress- and mitosis-responsive phosphorylation site on NIFK. Stress induces Ser247 phosphorylation through p38 mitogen-activated protein kinases (p38 MAPKs) and MSK1 (also known as RPS6KA5). Independently of stress, Ser247 is phosphorylated during mitosis by Aurora B (AURKB). In vitro assays confirm that MSK1 and Aurora B directly phosphorylate Ser247. During mitosis, Ser247 phosphorylation acts as a priming event enabling extensive multisite phosphorylation of NIFK. Mutation of Ser247 (S247A) abolishes this phosphorylation cascade but does not impair recruitment of NIFK to mitotic chromosomes. Nonetheless, cells with a NIFK S247A mutation display a delay in mitotic entry. Whether S247A mutation affects the ribosome biogenesis function of NIFK is not clear. These findings reveal that Ser247 is a hub integrating stress and mitotic cues, and establish it as a priming site for mitotic hyperphosphorylation of NIFK.

Indexed as

MitosisNuclear ProteinsStress, PhysiologicalAurora Kinase BHeLa CellsHumansp38 Mitogen-Activated Protein KinasesPhosphorylationRibosomal Protein S6 Kinases, 90-kDaSerineAURKB protein, humanAurora Kinase BNuclear Proteinsp38 Mitogen-Activated Protein KinasesRibosomal Protein S6 Kinases, 90-kDaSerineKi-67MitosisNIFKRibotoxic stress

Identifiers

PMID42504587
PMCPMC13571814

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.